Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial

S. Wolinsky, Jerry; A. Narayana, Ponnada; O’Connor, Paul; K. Coyle, Patricia; C. Ford, Corey; P. Johnson, Kenneth; Miller, Aaron; Caminero Pardo, L.; Kadosh, Shaul; Ladkani, David; Trial Study Group, PROMiSe

doi:10.1002/ana.21079

Public

Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial

Published in Annals of Neurology • Jan 1, 2007

Authors:

Jerry S. Wolinsky

Ponnada A. Narayana

Paul O’Connor

Abstract

OBJECTIVE: To determine whether glatiramer acetate (GA) slows accumulation of disability in primary progressive multiple sclerosis. METHODS: A total of 943 patients with primary progressive multiple sclerosis were randomized to GA or placebo (PBO) in this 3-year, double-blind trial. The primary end ...

Subject

Glatiramer acetate

Expanded Disability Status Scale

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!